Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

 

Gainers

  • Palisade Bio (NASDAQ:PALI) stock rose 59.0% to $1.28 during Tuesday's pre-market session. The company's market cap stands at $23.3 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Geovax Labs (NASDAQ:GOVX) stock rose 27.56% to $1.99. The company's market cap stands at $14.1 million.
  • SenesTech (NASDAQ:SNES) shares rose 19.44% to $0.86. The market value of their outstanding shares is at $10.4 million.
  • Alzamend Neuro (NASDAQ:ALZN) shares moved upwards by 18.01% to $1.31. The company's market cap stands at $118.0 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 15.45% to $1.27. The company's market cap stands at $44.7 million.
  • Stealth BioTherapeutics (NASDAQ:MITO) stock rose 12.1% to $0.75. The market value of their outstanding shares is at $43.1 million.

 

Losers

  • Applied Genetic (NASDAQ:AGTC) stock decreased by 29.4% to $1.27 during Tuesday's pre-market session. The company's market cap stands at $54.5 million.
  • Statera BioPharma (NASDAQ:STAB) stock fell 28.51% to $0.42. The market value of their outstanding shares is at $15.2 million.
  • ORIC Pharmaceuticals (NASDAQ:ORIC) shares decreased by 16.92% to $5.55. The market value of their outstanding shares is at $218.5 million. As per the press release, Q4 earnings came out yesterday.
  • Cue Health (NASDAQ:HLTH) stock decreased by 13.56% to $7.85. The company's market cap stands at $1.1 billion.
  • MorphoSys (NASDAQ:MOR) stock fell 11.65% to $6.3. The company's market cap stands at $860.5 million. As per the press release, Q4 earnings came out 4 days ago.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares fell 10.93% to $1.63. The market value of their outstanding shares is at $13.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.